SCHEMBL5655893

SCHEMBL5655893

CCOc1ccccc1N(CCCN1CCN(c2cc(C)ccc2C)CC1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
DRD2 P14416 5/20 0.48
DRD4 P21917 4/20 0.48
DRD3 P35462 4/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 2/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
POLB P06746 2/20 0.46
MAPK1 P28482 1/20 0.46
TP53 P04637 3/20 0.45
MAPT P10636 3/20 0.45
OPRM1 P35372 1/20 0.45
HTR1A P08908 3/20 0.45
HTR2A P28223 3/20 0.45
HTR7 P34969 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5666060 0.91 MEN1 (0.55) MEN1KMT2ADRD2DRD4DRD3
SCHEMBL5655833 0.87 OPRM1 (0.55) DRD2DRD4DRD3NPSR1MAPT
SCHEMBL5656018 0.86 KCNH2 (0.54) MEN1KMT2ADRD2DRD4DRD3
SCHEMBL5655903 0.85 DRD2 (0.50) DRD2DRD4DRD3LMNAOPRM1
SCHEMBL5654884 0.85 DRD2 (0.61) MEN1KMT2ADRD2DRD3ALDH1A1
SCHEMBL5656348 0.85 MEN1 (0.52) MEN1KMT2ADRD2DRD4DRD3
SCHEMBL5666364 0.84 HTR1A (0.50) DRD2DRD4DRD3OPRM1HTR1A
SCHEMBL5656115 0.84 TP53 (0.51) KMT2ADRD2DRD4DRD3ALDH1A1
SCHEMBL5657181 0.82 OPRM1 (0.54) DRD2DRD4DRD3ALDH1A1TSHR
SCHEMBL5655939 0.81 OPRM1 (0.57) DRD4SMN1; SMN2OPRM1HTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof CEREP (FR) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof HTR4, HTR5A, HTR3C MEN1 3474/4885KMT2A 2124/4885DRD2 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.